HCA Healthcare, Inc.

HCA Healthcare Medical Care Facilities

HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.

457.58 10.92 −2.33%
Market cap
$101.4B
P/E
15.3×
Fwd P/E
12.3×
Dividend yield
0.67%
F-score
7/9
Altman Z
2.80
Beneish M
−2.87
Dividend safety
78/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

16.47 16.45 16.27 13.05
P/S ratio
1.33 1.46 1.39 1.10
P/FCF ratio
12.26 14.35 13.35 14.34
P/Operating CF
22.48 46.79 52.54 36.82
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.92 2.06 2.00 1.73
EV/EBITDA
9.39 9.98 9.75 8.50
EV/Operating CF
11.12 12.33 11.76 12.11
EV/FCF
17.63 20.26 19.29 22.46
Quick Ratio
0.64 0.73 0.64 0.77
Current Ratio
0.85 0.97 0.83 0.99
Net Debt/EBITDA
11.22 11.02 12.35 12.06
Debt/Assets
74.50% 76.57% 78.15% 78.61%
Debt/Equity
(20.62) (16.78) (16.13) (15.49)
Asset Turnover
1.25 1.26 1.26 1.27
Operating CF/Net income
2.69 1.26 1.24 1.37
Capex/Depreciation
(1.44) (1.61) (1.19) (1.29)
Interest Coverage
5.31 5.60 4.92 5.15
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
43.65% 42.84% 43.35% 40.98%
Intangible Assets out of Total Assets
0.17 0.17 0.17 0.17
Share Based Compensation of Revenue
0.54% 0.51% 0.45% 0.42%
Graham Net Nets
(0.47) (0.43) (0.46) (0.57)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
6.07% 6.08% 6.14% 7.66%
Free Cash Flow Yield
8.16% 6.97% 7.49% 6.97%
Revenue per Share
82.27 82.54 85.47 91.73
Operating CF per Share
18.96 9.98 9.01 10.59
Capex per Share
(5.53) (6.30) (5.00) (5.58)
Free Cash Flow per Share
13.43 3.68 4.00 5.01
Cash per Share
4.28 4.40 4.20 4.59
Shareholders Equity per Share
(9.27) (11.72) (13.32) (14.55)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(9.27) (11.72) (13.32) (14.55)
Free Cash Flow
3,128.00 870.00 895.00 1,104.00
Working Capital
(2,611.00) (567.00) (3,206.00) (122.00)
Capital Expenditures
(1,288.00) (1,489.00) (1,119.00) (1,231.00)
Net Current Asset Value
(46,621.00) (47,708.00) (48,376.00) (49,269.00)
EV/EBIT
12.21 12.94 12.70 11.10
Capex to Sales
0.07 0.08 0.06 0.06
Price to Operating Income
8.49 9.16 8.79 7.08
Other line items
Average Receivables
10,171.50 10,809.00 11,206.00 11,370.00
Average Payables
4,393.50 4,467.50 4,647.00 4,501.00
Average Inventory
1,755.00 1,695.00 1,737.50 1,727.00
Average Assets
59,603.00 60,116.50 60,624.00 61,393.00
Average Common Equity
(686.50) (1,108.00) (1,708.00) (2,223.50)

Fold the line items

Columns are period end dates